A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to BioNTech on April 9 for "RNA constructs and uses thereof" (German, American Inventors)

Patent Issued for Monoclonal antibodies directed against programmed death-1 protein and their use in medicine (USPTO 11932693)

Three-year follow-up data from Phase 1 trial of BioNTech and Genentech's mRNA cancer vaccine candidate autogene cevumeran show effective T cell responses and delayed tumor recurrence in patients with resected pancreatic ductal adenocarcinoma

Biontech SE Seeks Patent for RNA Manufacturing

INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "NUCLEIC ACID COMPLEXES AND USES THEREOF"

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count